VCIM
PYXS icon

Velan Capital Investment Management’s Pyxis Oncology PYXS Stock Holding History

Velan Capital Investment Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,000
Closed -$46K – 52
2025
Q4 		$46K Sell
40,000
-15,000
-27% -$52.9K 0.03% 45
2025
Q3 		$122K Buy
55,000
+15,000
+38% +$21.6K 0.11% 38
2025
Q2 		$44K Buy
+40,000
New +$45.1K 0.04% 48

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Velan Capital Investment Management's PYXS Position: Q1 2026 in Review

Velan Capital Investment Management sold out of Pyxis Oncology (PYXS) in Q1 2026, closing a stake of 40,000 shares — an estimated $46K sold.

Velan Capital Investment Management first reported a position in PYXS in Q2 2025 and held it in 3 quarters. The position peaked at $122K in Q3 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Velan Capital Investment Management reported no remaining Pyxis Oncology position as of Q1 2026 after selling out during the quarter.
  • Velan Capital Investment Management sold 40,000 Pyxis Oncology shares in Q1 2026, an estimated $46K.
  • Velan Capital Investment Management first reported a position in Pyxis Oncology in Q2 2025 and held it in 3 quarters.
  • Velan Capital Investment Management's Pyxis Oncology position peaked at $122K in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.